JSPRW Insider Trading - Jasper Therapeutics, Inc.

所有內部人士

内部人士情绪分数

“内部人士情绪分数”用于查找被公司内部人士购入的公司。

它是一个复杂的多因素量化模型的结果，该模型能够辨识具有最高内部人士累积持有水平的公司。该评分模型结合了内部人士在过去90天内买入的净数量、总买入股份占流通股比例，以及内部人士拥有的总股份的指标。该分数的范围从0到100，数值越高表示相对于同行业而言具有更高程度的内部人士持股水平，50为平均值。

更新频率：每日

参阅“内部人士首选”，该清单呈现被内部人士购入最多的公司。

查阅“高排名股票”

高管情绪分数

“高管情绪分数”用于查找被公司管理层购入的公司。

根据定义，公司高管是公司内部人士，但与其他内部人士（10%的股东和董事会成员）不同，公司高管每天在公司工作，而且他们使用自己的资金进行交易。（10%的股东和董事会成员通常是基金经理，管理着其他人的资金。）因此，公司高管进行的内幕交易更为重要，应该被适当地重视和关注。

如同“内部人士情绪分数”，“高管情绪分数”也是一个复杂的多因素量化模型的计算结果，该模型能够辨识具有最高高管累积持有水平的公司。

更新频率：每日

参阅“内部人士首选”，该清单呈现被内部人士购入最多的公司。

查阅“高排名股票”

关键内部人士指标

此表格显示了公司在各种内部人士指标上的排名。百分位数排名显示了这家公司在美国市场与其他公司相比的表现。排名越高表明公司所处状况越好。

举例来说，一般认为内部人士的买入是一个积极的指标，因此具有更多内部人士买入的公司将排名高于那些内部人士买入较少（甚至有内部人士卖出）的公司。

内部人士买入净数（排名）

N/A

内部人士买入净数是过去90天内买入的内部人士总数减去卖出的内部人士总数。以百分位排名显示（范围从0到100%）。

内部人士买入占流通股比例（排名）

N/A

内部人士买入占流通股比例是内部人士在过去90天内买入的股份总数减去卖出的股份总数，除以总流通股数并乘以100。

内幕交易图表

以下图表显示了Jasper Therapeutics, Inc. - Equity Warrant内部人士交易。内部人士包括公司的高管、董事或重要投资者。一般而言，基于内幕、非公开信息进行交易是非法的。这并不意味着他们在自己的公司进行任何交易都是非法的。但是，他们必须通过Form 4向美国证券交易委员会（SEC）报告所有交易。

内部人员名单及盈利指标

这张表格显示已知的内部人士名单，从向美国证券交易委员会（SEC）披露的申报文件中自动生成。除了姓名、当前职位和董事、高管或10%所有人的任命外，我们还提供了最新披露的持股信息。此外，我们尽可能提供内部人士的历史交易表现。历史交易表现是内部人士实际进行的公开市场买入交易表现的加权平均值。有关此计算方式的更多信息，请查看YouTube网络研讨会。

See our leaderboard of most profitable insider traders.

内部人士	持股数量	分拆调整
LLP Abingworth 10% Owner - [10%]	5,628,558	1,066,189
Amplitude Healthcare Holdings LLC 10% Owner - [10%]	2,300,000	230,000
Carlyle Group L.P. -	1,066,189	1,066,189
Kenneth F Clifford -	2,300,000	230,000
Peter R Dolan	0
Kurt Von Emster Director - [D]	21,175	2,118
Fredric N Eshelman	0
Anna Louise French Director - [D]	23,750	2,375
Glazer Capital, Llc 10% Owner - [10%]	895,059	895,059
Paul J Glazer 10% Owner - [10%]	895,059	895,059

内部人士	持股数量	分拆调整
Howard I Hoffen -	2,300,000	230,000
Heller Kevin N.	7,500
Vishal Kapoor Director - [D]	87,500	8,750
Lawrence Otto Klein Director - [D]	24,500	2,450
William Lis Director - [D]	53,521	5,352
Ernest Mario	0
Ron Martell President, CEO & Director, Director - [D] [O]	331,188	33,119
Mark Mcdade 10% Owner - [10%]	5,852,982	851,965
Jeetinder Singh Mahal Chief Operating Officer - [O]	25,009	25,009
Chris Nolet Director - [D]	32,500	3,250

内部人士	持股数量	分拆调整
Qiming U.S. Healthcare Fund II, L.P. 10% Owner - [10%]	8,519,648	851,965
Qiming U.S. Healthcare GP II, LLC 10% Owner - [10%]	5,852,982	851,965
Finance Ltd Roche 10% Owner - [10%]	4,624,606	454,961
Holding Ltd Roche 10% Owner - [10%]	4,549,606	454,961
Glenn Reicin	0
Judith Anne Shizuru Director - [D]	1,159,012	115,901
Edwin Jonathan Tucker Chief Medical Officer - [O]	400	400
Balaji Venkataraman 10% Owner - [10%]	2,300,000	1,188,500
Velan Capital Investment Management LP 10% Owner - [10%]	1,188,500	1,188,500
Thomas G Wiggans Director - [D]	50,000	5,000

Report errors via our new Insider Auditing Tool

跟踪内部人士买入记录 - 短期收益分析

在这一部分，我们分析了在 JSPRW / Jasper Therapeutics, Inc. - Equity Warrant 中进行的每笔非计划的公开市场内部人士买入的盈利情况。这种分析有助于了解内部人士是否持续产生异常的回报，以及是否值得跟踪。该分析基于每笔交易后一年的情况，结果仅为理论值。 .

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期	内部人士	报告股数	报告价格	经调整股数	经调整价格	成本基础	达到最高利润的天数	达到最高利润时的价格	最高利润($)	最高回报率（%）
2024-02-08	Velan Capital Investment Management LP	350,000	12.9500	350,000	12.9500	4,532,500	60	30.0000	5,967,500	131.66
2024-02-08	Carlyle Group L.P.	190,000	12.9500	190,000	12.9500	2,460,500
2023-11-28	WIGGANS THOMAS G	10,000	0.6486	1,000	6.4860	6,486
2023-11-21	WIGGANS THOMAS G	10,000	0.6383	1,000	6.3830	6,383
2023-11-20	WIGGANS THOMAS G	10,000	0.6309	1,000	6.3090	6,309
2023-11-17	WIGGANS THOMAS G	10,000	0.5966	1,000	5.9660	5,966
2023-11-16	WIGGANS THOMAS G	10,000	0.5965	1,000	5.9650	5,965
2023-01-27	Carlyle Group L.P.	3,133,333	1.5000	313,333	15.0000	4,700,000
2023-01-27	Qiming U.S. Healthcare Fund II, L.P.	2,666,666	1.5000	266,667	15.0000	3,999,999

经调整价格已按拆股调整。经调整股数已按拆股调整。

JSPRW / Jasper Therapeutics, Inc. - Equity Warrant Insider Trades

追踪内部人士卖出记录 - 短期亏损分析

在这一部分，我们分析了在 JSPRW / Jasper Therapeutics, Inc. - Equity Warrant 中进行的每笔非计划的公开市场内部人士卖出所达成的短期亏损规避。如果存在持续的亏损规避模式，可能表明未来的内部人士卖出交易预示着价格的下跌。该分析基于每笔交易后一年的情况，结果仅为理论值。 .

以下表格显示了最近的自动交易计划之外的公开市场买入。

交易日期	内部人士	报告股数	报告价格	经调整股数	经调整价格	成本基础	达到最低利润的天数	达到最低利润时的价格	避免的最高损失金额($)	避免的最高损失率($)
2023-04-14	French Anna Louise	7,000	1.4800	700	14.8000	10,360	243	4.235	-7,396	-71.39
2023-04-13	Lis William	8,500	1.4400	850	14.4000	12,240
2023-04-13	EMSTER KURT VON	9,075	1.4903	908	14.9030	13,524
2023-01-25	ROCHE HOLDING LTD	75,000	1.8900	7,500	18.9000	141,750
2021-04-23	GLAZER CAPITAL, LLC	151,719	9.9200	151,719	9.9200	1,505,052
2021-04-21	GLAZER CAPITAL, LLC	1,164	9.9200	1,164	9.9200	11,547
2021-04-19	GLAZER CAPITAL, LLC	2,060	9.9700	2,060	9.9700	20,538
2021-02-22	GLAZER CAPITAL, LLC	698	10.5000	698	10.5000	7,329
2021-02-19	GLAZER CAPITAL, LLC	2,112	10.5000	2,112	10.5000	22,176

经调整价格已按拆股调整。经调整股数已按拆股调整。

交易历史记录

点击链接图标即可查看完整的交易历史记录。作为 10b5-1 自动交易计划的一部分进行报告的交易，将在标记为 10b-5 的列中显示 X。

备案日期	交易日期	表格	内部人士	股票代码	证券种类	代码	直接	执行价格	单位价格	股数变化	价值变化 (1K)	剩余期权	剩余股份
2024-12-12	2024-12-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	S - Sale	D		22.1100	-900	-20		25,009
2024-12-12	2024-12-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	M - Exercise	D		7.1000	900	6		25,909
2024-09-12	2024-09-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	S - Sale	D		21.2263	-900	-19		25,009
2024-09-12	2024-09-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	M - Exercise	D		7.1000	900	6		25,909
2024-06-12	2024-06-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	S - Sale	D		24.1550	-900	-22		25,009
2024-06-12	2024-06-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	M - Exercise	D		7.1000	900	6		25,909
2024-06-10	2024-06-07	4	Tucker Edwin Jonathan	JSPR	Voting Common Stock	A - Award	D		4.1735	400	2		400
2024-03-12	2024-03-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	S - Sale	D		26.4358	-900	-24		25,009
2024-03-12	2024-03-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	M - Exercise	D		7.1000	900	6		25,909
2024-02-12	2024-02-08	4	Carlyle Group L.P. See footnotes	JSPR	Voting Common Stock	P - Purchase	I		12.9500	190,000	2,460		1,066,189
2024-02-09	2024-02-08	4	Velan Capital Investment Management LP By Velan Capital Master Fund LP	JSPR	Common Stock, par value $0.0001 per share	P - Purchase	I		12.9500	350,000	4,532		1,188,500
2023-11-30	2023-11-28	4	WIGGANS THOMAS G	JSPR	Voting Common Stock	P - Purchase	D		0.6486	10,000	6		50,000
2023-11-22	2023-11-21	4	WIGGANS THOMAS G	JSPR	Voting Common Stock	P - Purchase	D		0.6383	10,000	6		40,000
2023-11-20	2023-11-20	4	WIGGANS THOMAS G	JSPR	Voting Common Stock	P - Purchase	D		0.6309	10,000	6		30,000
2023-11-20	2023-11-17	4	WIGGANS THOMAS G	JSPR	Voting Common Stock	P - Purchase	D		0.5966	10,000	6		20,000
2023-11-20	2023-11-16	4	WIGGANS THOMAS G	JSPR	Voting Common Stock	P - Purchase	D		0.5965	10,000	6		10,000
2023-10-13	2023-10-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	F - Taxes	D		0.8500	-37,126	-32		250,097
2023-10-13	2023-10-12	4	MARTELL RON	JSPR	Voting Common Stock	F - Taxes	D		0.8500	-87,531	-74		331,188
2023-10-13	2023-10-13	4	Lis William	JSPR	Voting Common Stock	S - Sale	D		0.8508	-7,965	-7		53,521
2023-06-13	2023-06-13	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	S - Sale	D		1.6572	-9,000	-15		287,223
2023-06-13	2023-06-13	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	M - Exercise	D		0.7100	9,000	6		296,223
2023-04-14	2023-04-14	4	French Anna Louise	JSPR	Voting Common Stock	S - Sale	D		1.4800	-7,000	-10		23,750
2023-04-14	2023-04-13	4	EMSTER KURT VON	JSPR	Voting Common Stock	S - Sale	D		1.4903	-9,075	-14		21,175
2023-04-14	2023-04-12	4	MARTELL RON	JSPR	Voting Common Stock	F - Taxes	D		1.4600	-87,531	-128		418,719
2023-04-14	2023-04-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	F - Taxes	D		1.4600	-37,126	-54		287,223
2023-04-14	2023-04-13	4	Lis William	JSPR	Voting Common Stock	S - Sale	D		1.4400	-8,500	-12		61,486
2023-04-11	2023-01-27	4	Qiming U.S. Healthcare Fund II, L.P.	JSPR	Voting Common Stock	P - Purchase	D		1.5000	2,666,666	4,000		8,519,648
2023-02-27		3/A	Kapoor Vishal	JSPR	Voting Common Stock		D						43,750
2023-02-03		3	Morgan Adam By Velan Capital Master Fund LP	JSPR	Common Stock, par value $0.0001 per share		I						8,385,000
2023-02-03		3	Morgan Adam By Avego Healthcare Capital, L.P.	JSPR	Common Stock, par value $0.0001 per share		I						2,453,281
2023-01-31	2023-01-27	4	Carlyle Group L.P. See footnotes	JSPR	Voting Common Stock	P - Purchase	I		1.5000	3,133,333	4,700		8,761,891
2023-01-26	2023-01-25	4	ROCHE HOLDING LTD	JSPR	Voting Common Stock	S - Sale	I		1.8900	-75,000	-142		4,549,606
2022-10-13	2022-10-12	4	MARTELL RON	JSPR	Voting Common Stock	A - Award	D			506,250			506,250
2022-10-13	2022-10-12	4	Klein Lawrence Otto	JSPR	Voting Common Stock	A - Award	D			24,500			24,500
2022-10-13	2022-10-12	4	EMSTER KURT VON	JSPR	Voting Common Stock	A - Award	D			30,250			30,250
2022-10-13	2022-10-12	4	Shizuru Judith Anne	JSPR	Voting Common Stock	A - Award	D			29,500			1,159,012
2022-10-13	2022-10-12	4	Mahal Jeetinder Singh	JSPR	Voting Common Stock	A - Award	D			214,722			324,349
2022-10-13	2022-10-12	4	Nolet Chris	JSPR	Voting Common Stock	A - Award	D			32,500			32,500
2022-10-13	2022-10-12	4	Lis William	JSPR	Voting Common Stock	A - Award	D			29,500			69,986
2022-10-13	2022-10-12	4	French Anna Louise	JSPR	Voting Common Stock	A - Award	D			30,750			30,750
2022-08-11		3	Carlyle Genesis UK LLC See footnotes	JSPR	Voting Common Stock		I						5,628,558
2022-06-28	2022-06-27	4	Lis William	JSPR	Voting Common Stock	S - Sale	D		2.0775	-24,743	-51		40,486
2022-06-28	2022-06-24	4	Lis William	JSPR	Voting Common Stock	S - Sale	D		2.0220	-24,743	-50		65,229
2022-04-08	2022-04-07	4	Mahal Jeetinder Singh	JSPR	Stock Option (right to buy)	A - Award	D	3.12		48,441		48,441
2022-03-23	2022-03-21	4	Klein Lawrence Otto	JSPR	Stock Option (right to buy)	A - Award	D	3.54		78,045		78,045
2022-03-23	2022-03-21	4	MARTELL RON	JSPR	Stock Option (right to buy)	A - Award	D	3.54		1,704,328		1,704,328
2022-03-23	2022-03-21	4	Heller Kevin N.	JSPR	Stock Option (right to buy)	A - Award	D	3.54		7,500		7,500
2022-03-23	2022-03-21	4	EMSTER KURT VON	JSPR	Stock Option (right to buy)	A - Award	D	3.54		78,045		78,045
2022-03-23	2022-03-21	4	Shizuru Judith Anne	JSPR	Stock Option (right to buy)	A - Award	D	3.54		78,045		78,045
2022-03-23	2022-03-21	4	Nolet Chris	JSPR	Stock Option (right to buy)	A - Award	D	3.54		78,045		78,045
2022-03-23	2022-03-21	4	Mahal Jeetinder Singh	JSPR	Stock Option (right to buy)	A - Award	D	3.54		87,272		87,272
2022-03-23	2022-03-21	4	Mahal Jeetinder Singh	JSPR	Stock Option (right to buy)	A - Award	D	3.54		7,500		7,500
2022-03-23	2022-03-21	4	French Anna Louise	JSPR	Stock Option (right to buy)	A - Award	D	3.54		78,045		78,045
2022-03-23	2022-03-21	4	Lis William	JSPR	Stock Option (right to buy)	A - Award	D	3.54		100,000		100,000
2022-03-23	2022-03-21	4	Lis William	JSPR	Stock Option (right to buy)	A - Award	D	3.54		89,972		89,972
2022-03-23	2022-03-21	4	Lis William	JSPR	Stock Option (right to buy)	A - Award	D	3.54		7,500		7,500
2022-03-23	2022-03-21	4	Lis William	JSPR	Voting Common Stock	A - Award	D			89,972			89,972
2022-03-23	2022-03-21	4	Abingworth LLP See footnotes	JSPR	Stock Option (right to buy)	A - Award	I	3.54		78,045		78,045
2021-10-04		3	ROCHE FINANCE LTD	JSPR	Voting Common Stock		D						4,624,606
2021-10-01		3	Abingworth LLP By Abingworth Bioventures VII, LP	JSPR	Common Stock		I						5,628,558
2021-10-01		3	EMSTER KURT VON By Abingworth Bioventures VII, LP	JSPR	Common Stock		I						5,628,558
2021-10-01		3	Shizuru Judith Anne	JSPR	Voting Common Stock		D						1,129,512
2021-10-01		3	Mahal Jeetinder Singh	JSPR	Voting Common Stock		D						109,627
2021-10-01		3	MCDADE MARK	JSPR	Voting Common Stock		D						5,852,982
2021-09-28	2021-09-24	4	Amplitude Healthcare Holdings LLC	JSPR	Class B Common Stock	M - Exercise	D			2,300,000		0
2021-09-28	2021-09-24	4	Amplitude Healthcare Holdings LLC	JSPR	Class B Common Stock	D - Sale to Issuer	D			200,000		0
2021-09-28	2021-09-24	4	Amplitude Healthcare Holdings LLC	JSPR	Voting Common Stock	M - Exercise	D			2,300,000			2,300,000
2021-09-28	2021-09-24	4	VENKATARAMAN BALAJI	JSPR	Class B Common Stock	M - Exercise	I			2,300,000		0
2021-09-28	2021-09-24	4	VENKATARAMAN BALAJI	JSPR	Class B Common Stock	D - Sale to Issuer	I			200,000		0
2021-09-28	2021-09-24	4	VENKATARAMAN BALAJI	JSPR	Voting Common Stock	M - Exercise	I			2,300,000			2,300,000
2021-09-28	2021-09-24	4	HOFFEN HOWARD I	JSPR	Class B Common Stock	M - Exercise	I			2,300,000		0
2021-09-28	2021-09-24	4	HOFFEN HOWARD I	JSPR	Class B Common Stock	D - Sale to Issuer	I			200,000		0
2021-09-28	2021-09-24	4	HOFFEN HOWARD I	JSPR	Voting Common Stock	M - Exercise	I			2,300,000			2,300,000
2021-09-28	2021-09-24	4	Clifford Kenneth F	JSPR	Class B Common Stock	M - Exercise	I			2,300,000		0
2021-09-28	2021-09-24	4	Clifford Kenneth F	JSPR	Class B Common Stock	D - Sale to Issuer	I			200,000		0
2021-09-28	2021-09-24	4	Clifford Kenneth F	JSPR	Voting Common Stock	M - Exercise	I			2,300,000			2,300,000
2021-04-23	2021-04-23	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		9.9200	-151,719	-1,505		895,059
2021-04-23	2021-04-21	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		9.9200	-1,164	-12		1,046,778
2021-04-21	2021-04-19	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		9.9700	-2,060	-21		1,047,942
2021-02-22	2021-02-22	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.5000	-698	-7		1,050,002
2021-02-22	2021-02-19	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.5000	-2,112	-22		1,050,700
2021-02-22	2021-02-18	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.4500	-10,000	-104		1,052,812
2021-02-09	2021-02-05	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.4000	-212	-2		1,062,812
2021-01-19	2021-01-14	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.4000	-101	-1		1,063,024
2021-01-12	2021-01-08	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.2500	-10,000	-102		1,063,125
2020-12-31	2020-12-30	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.2500	-75	-1		1,073,125
2020-12-31	2020-12-29	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.2500	-18	-0		1,073,200
2020-12-28	2020-12-28	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.2000	-10,000	-102		1,073,218
2020-12-28	2020-12-22	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.1500	-10,000	-102		1,083,218
2020-12-15	2020-12-15	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.1500	-10,000	-102		1,093,218
2020-12-15	2020-12-14	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.0500	-5,000	-50		1,103,218
2020-12-15	2020-12-11	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.0500	-5,000	-50		1,108,218
2020-12-09	2020-12-07	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.0500	-1	-0		1,113,218
2020-12-09	2020-09-04	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A common stock, par value $0.0001 per share	S - Sale	I		10.7300	-11	-0		1,113,219
2020-09-23	2020-09-21	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A Common Stock	S - Sale	I		10.0000	-1,000	-10		1,113,230
2020-09-18	2020-09-18	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A Common Stock	S - Sale	I		10.0000	-1,000	-10		1,114,230
2020-09-18	2020-09-16	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A Common Stock	S - Sale	I		9.9900	-20	-0		1,115,230
2020-09-15	2020-09-15	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A Common Stock	S - Sale	I		9.9900	-800	-8		1,115,250
2020-09-15	2020-09-11	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A Common Stock	S - Sale	I		9.9900	-682	-7		1,116,050
2020-09-10	2020-09-08	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A Common Stock	S - Sale	I		9.9900	-1	-0		1,116,732
2020-08-17	2020-08-17	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A Common Stock	S - Sale	I		9.9900	-1,699	-17		1,116,733
2020-08-17	2020-08-13	4	GLAZER CAPITAL, LLC See Footnote 1.	AMHC	Class A Common Stock	S - Sale	I		9.9900	-1,699	-17		1,118,432
2020-08-17		3	GLAZER PAUL J See Footnote 1.	AMHC	Class A Common Stock		I						1,120,131
2020-01-07	2020-01-03	4	Amplitude Healthcare Holdings LLC	AMHCU	Class B Common Stock	J - Other	D			-375,000		2,500,000
2020-01-07	2020-01-03	4	Clifford Kenneth F	AMHCU	Class B Common Stock	J - Other	I			-375,000		2,500,000
2020-01-07	2020-01-03	4	HOFFEN HOWARD I	AMHCU	Class B Common Stock	J - Other	I			-375,000		2,500,000
2020-01-07	2020-01-03	4	VENKATARAMAN BALAJI	AMHCU	Class B Common Stock	J - Other	I			-375,000		2,500,000

非衍生或衍生证券的公开市场或私下买入

非衍生或衍生证券的公开市场或私下卖出

公司向内部人员授予、奖励或以其他方式获取证券（例如股票期权）

衍生工具转换

将证券卖出或转让回公司

使用从公司收到的证券的一部分来支付行使价或税务负担。

内部人士赠送或接收他人赠送公司股票

股权掉期和类似的避险交易

行使或转换从公司获得的衍生证券（例如期权）

内部人士通过Form 4自愿报告的一笔交易

其他（附有交易描述的脚注）

JSPRW / Jasper Therapeutics, Inc. - Equity Warrant - Insider Trading and Ownership Report - SEC Form 3, 4, 5